Price target
41.690.000.00%
The 13 analysts offering 1 year price forecasts for DNLI have a max estimate of — and a min estimate of —.
Analyst rating
Based on 17 analysts giving stock ratings to DNLI in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
DNLI EPS for the last quarter is −0.63 USD despite the estimation of −0.60 USD. In the next quarter EPS is expected to reach −0.81 USD. Track more of Denali Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Denali Therapeutics Inc. revenue is expected to reach 13.40 M USD. Check out Denali Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, DNLI price target is 41.69 USD with a max estimate of 90.00 USD and a min estimate of 28.00 USD. Check if this forecast comes true in a year, meanwhile watch Denali Therapeutics Inc. stock price chart and keep track of the current situation with DNLI news and stock market news.
We've gathered opinions of 17 analysts rating DNLI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.